Valiant Pharmaceuticals

Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals International, is a global specialty pharmaceutical and medical device company headquartered in Laval, Canada. The company operates through several key segments, including Salix Pharmaceuticals (gastroenterology), Ortho Dermatologics (dermatology), and a majority stake in Bausch + Lomb (eye health). Bausch Health's portfolio features prominent products such as Xifaxan for irritable bowel syndrome and Relistor for opioid-induced constipation. Following a period of significant restructuring and a name change in 2018, the company has focused on reducing debt and advancing its R&D pipeline in core therapeutic areas. It remains a major player in the global healthcare market with a diverse range of pharmaceutical products, contact lenses, and surgical devices.